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Barrier protective effects of 2,4,6-trihydroxy-3-geranyl acetophenone on 
lipopolysaccharides-stimulated inflammatory responses in human umbilical vein 
endothelial cells 
 
ABSTRACT 
Pharmocological relevance: 2,4,6-trihydroxy-3-geranyl acetophenone (tHGA), is a 
phloroglucinol compound found naturally in Melicope ptelefolia. Melicope ptelefolia has 
been used traditionally for centuries as natural remedy for wound infections and 
inflammatory diseases. 
Aim of the study: Endothelial barrier dysfunction is a pathological hallmark of many diseases 
and can be caused by lipopolysaccharides (LPS) stimulation. Therefore, this study aims to 
investigate the possible barrier protective effects of tHGA upon LPS-stimulated inflammatory 
responses in human umbilical vein endothelial cells (HUVECs). 
Materials and methods: HUVECs were pretreated with tHGA prior to LPS stimulation, where 
inflammatory parameters including permeability, monocyte adhesion and migration, and 
release of pro-inflammatory mediators were examined. Additionally, the effect of tHGA on 
F-actin rearrangement and adhesion protein expression of LPS-stimulated HUVECs was 
evaluated. 
Results: It was found that pretreatment with tHGA inhibited monocyte adhesion and 
transendothelial migration, reduced endothelial hyperpermeability and secretion of 
prostaglandin E2 (PGE2). Additionally, tHGA inhibited cytoskeletal rearrangement and 
adhesion protein expression on LPS-stimulated HUVECs. 
Conclusion: As the regulation of endothelial barrier dysfunction can be one of the therapeutic 
strategies to improve the outcome of inflammation, tHGA may be able to preserve vascular 
barrier integrity of endothelial cells following LPS-stimulated dysfunction, thereby endorsing 
its potential usefulness in vascular inflammatory diseases. 
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